Tang Capital Management’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.36M | Hold |
|
|||||
|
2025
Q2 | $3.73M | Hold |
|
|||||
|
2025
Q1 | $4.11M | Buy |
|
|||||
|
2024
Q4 | $5.04M | Buy |
|
|||||
|
2024
Q3 | $2.44M | Buy |
|
|||||
|
2024
Q2 | $1.82M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.5M | Hold |
|
|||||
|
2023
Q2 | $1.71M | Buy |
|
|||||
|
2023
Q1 | $1.37M | Buy |
|
|||||
|
2022
Q4 | $918K | Sell |
|
|||||
|
2022
Q3 | $7.21M | Hold |
|
|||||
|
2022
Q2 | $5.43M | Hold |
|
|||||
|
2022
Q1 | $9.68M | Buy |
|
|||||
|
2021
Q4 | $10.4M | Hold |
|
|||||
|
2021
Q3 | $10.4M | Hold |
|
|||||
|
2021
Q2 | $8.99M | Hold |
|
|||||
|
2021
Q1 | $9.5M | Hold |
|
|||||
|
2020
Q4 | $11.3M | Buy |
|
|||||
|
2020
Q3 | $10.1M | Hold |
|
|||||
|
2020
Q2 | $9.82M | Buy |
|
|||||
|
2020
Q1 | $5.68M | Buy |
|